Skip to content

Visualmed

Clinical trials summarized as Visual Abstracts

Menu
  • Home

VANISH Trial: VT Ablation versus Escalation of Antiarrhythmic Drugs

by adminPosted onMay 2, 2020July 24, 2020
Posted in Cardiovascular DiseaseTagged ablation, antiarrhthmic drugs, ICD, MI, tachycardia, ventricular tachycardia, VT

Post navigation

Prev VALIANT Trial: Valsartan, Captopril, or Both in MI complicated by HF
Next VERDICT Trial: Early Versus Standard Care Invasive Management of NSTEMI

Download the App

Recent Posts

  • Tocilizumab in hospitalized patients with COVID-19
  • VERTIS CV Trial: Ertugliflozin Effect on CV Outcomes in Type 2 Diabetes
  • EMPEROR Reduced Trial: Empagliflozin in HFrEF
  • REALITY Trial: Transfusion in Patients With Myocardial Infarction and Anemia
  • EAST AFNET 4 Trial: Early Rhythm control in Afib
Amphibious Theme by TemplatePocket ⋅ Powered by WordPress